The ITP Foundation's Board and Medical Advisory Panel is currently considering studies and relevant medical research to support in the year ahead.


The mission of the ITP Foundation [ITPF] is to increase awareness and improve the diagnosis and treatment of children and adolescents with Immune Thrombocytopenia. Laboratory or clinical research proposals are appropriate subjects for research support if they address important scientific questions regarding ITP mechanism, diagnosis, or treatment.

(We do not accept applications that focus on clinical trials in adults or thrombocytopenias due to non immune etiologies.)

Purpose of Grants

The ultimate goal of research supported by the ITPF is to gain a fuller understanding, enhance treatment, and produce a cure, for ITP.

Authority for Approval

Grants are made by the Board of Directors of the ITPF acting on the recommendations of the Medical Advisory Board. The ITPF reserves the right to change the terms and conditions of its Medical Research Funding initiative, from time to time, as it deems necessary.

Application Process

A request for a grant application is made to the ITPF. Please download the ITPF Policies and Instruction for Research Grants below.

ITPF Policies and Instructions for Research Grants

What We Do for ITP

As a non-profit organization focusing on ITP (Immune Thrombocytopenia), we seek to raise awareness of ITP among the general public, medical and health care professionals, and elected officials. In addition, we work to fund vital medical research into various aspects of ITP, including its cause, treatment and cure.

Helping Families


ITP Foundation Grants $19,110 to Yale University School of Medicine Research Project

A study being conducted at the Yale School of Medicine's Pediatric Hematology/Oncology center aimed at targeting the mechanism of action of IVIG in the treatment of ITP.


ITP Foundation fulfills $50,000 grant to the ICIS's research at the University Children's Hospital in Basel, Switzerland

Predisposing and Modulating Genetic Factors in Idiopathic Thrombocytopenic Purpura

A study being conducted at the Children's Hospital in Basel, Switzerland that has thus far exhibited the likely existence of a genetic susceptibility for ITP.


ITP Foundation grants $25,000 to the ICIS's research at the University Children's Hospital in Basel, Switzerland

Evan's Syndrome and Idiopathic Thrombocytopenic Purpura in Families

Celiacs Disease Is Not a Major Risk Factor for the Development of Childhood ITP.


ITP Foundation grants $75,000 to the PARC-ITP Study

Pediatric and Adult Intercontinental Registry of Chronic ITP (PARC-ITP Study)

donatenow logo

The ITP Foundation

facebook icon for column